UPDATED S2K GUIDELINES ON THE MANAGEMENT OF PEMPHIGUS VULGARIS AND FOLIACEUS INITIATED BY THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV)

Pascal   Joly; Barbara Horwath Horwath; Katerina   Patsatsi; Soner  Uzun; Rikke  Bech; Stefan  Beissert; Reuven   Bergman; Philippe  Bernard; Luca  Borradori; Marzia  Caproni; Frédéric  Caux; Giuseppe  Cianchini; Maryam  Daneshpazhooh; De  Dipankar; Marian  Dmochowski; Kossara  Drenovska; Jan  Ehrchen; Claudio  Feliciani; Matthias   Goebeler; Richard  Groves; Claudia  Guenther; Silke  Hofmann; Dimitrios  Ioannides; Cezary   Kowalewski; Ralf  Ludwig; Yen Loo  Lim; Branka Marinovic; Angelo Valerio  Marzano; José M.  Mascaró; Daniel  Mimouni; Dedee  F  Murrel; Carlo  Pincelli; Catherine Prost  Squarcioni; Miklós  Sárdy; Jane Setterfield; Eli  Sprecher; Snejina  Vassileva; Katarzyna  Wozniak; Savas  Yayli; Giovanna  Zambruno; Detlef  Zillikens; Michael  Hertl; Enno  Schmid

doi:10.1111/jdv.16752

UPDATED S2K GUIDELINES ON THE MANAGEMENT OF PEMPHIGUS VULGARIS AND FOLIACEUS INITIATED BY THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV)

Pascal Joly, Barbara Horwath Horwath, Katerina Patsatsi , Soner Uzun, Rikke Bech, Stefan Beissert, Reuven Bergman, Philippe Bernard, Luca Borradori, Marzia Caproni , Frédéric Caux, Giuseppe Cianchini, Maryam Daneshpazhooh, De Dipankar, Marian Dmochowski, Kossara Drenovska, Jan Ehrchen, Claudio Feliciani, Matthias Goebeler, Richard GrovesClaudia Guenther, Silke Hofmann, Dimitrios Ioannides, Cezary Kowalewski, Ralf Ludwig, Yen Loo Lim, Branka Marinovic, Angelo Valerio Marzano, José M. Mascaró, Daniel Mimouni, Dedee F Murrel, Carlo Pincelli, Catherine Prost Squarcioni , Miklós Sárdy, Jane Setterfield, Eli Sprecher, Snejina Vassileva, Katarzyna Wozniak, Savas Yayli , Giovanna Zambruno, Detlef Zillikens , Michael Hertl , Enno Schmid

Centre for Host Microbiome Interactions

Research output: Contribution to journal › Article › peer-review

186 Citations (Scopus)

148 Downloads (Pure)

Abstract

Abstract:
Background: Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost always fatal. Due to its rarity, only few randomized controlled therapeutic trials are available. Recently, rituximab has been approved as first-line treatment for moderate and severe pemphigus vulgaris in Europe and the USA.
Objectives: The Autoimmune blistering diseases Task Force of the European Academy of Dermatology and Venereology (EADV) has initiated a throughout update of the guideline for the management of patients with pemphigus.
Results: The guidelines for the management of pemphigus were updated and the degree of consent among all task force members was included. The final version of the guideline was consented by the European Dermatology Forum (EDF) and several patient organisations.

Original language	English
Journal	Journal of the European Academy of Dermatology and Venereology : JEADV
Early online date	24 Aug 2020
DOIs	https://doi.org/10.1111/jdv.16752
Publication status	E-pub ahead of print - 24 Aug 2020

Access to Document

10.1111/jdv.16752Licence: CC BY

Updated S2K Guidlines on_JOLY_Acc10Jul2020_GREEN AAMAccepted author manuscript, 532 KB

Cite this

Joly, P., Horwath, B. H., Patsatsi , K., Uzun, S., Bech, R., Beissert, S., Bergman, R., Bernard, P., Borradori, L., Caproni , M., Caux, F., Cianchini, G., Daneshpazhooh, M., Dipankar, D., Dmochowski, M., Drenovska, K., Ehrchen, J., Feliciani, C., Goebeler, M., ... Schmid, E. (2020). UPDATED S2K GUIDELINES ON THE MANAGEMENT OF PEMPHIGUS VULGARIS AND FOLIACEUS INITIATED BY THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV). Journal of the European Academy of Dermatology and Venereology : JEADV. Advance online publication. https://doi.org/10.1111/jdv.16752

@article{2d3e38a7688b45f3814533042a237d13,

title = "UPDATED S2K GUIDELINES ON THE MANAGEMENT OF PEMPHIGUS VULGARIS AND FOLIACEUS INITIATED BY THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV)",

abstract = "Abstract:Background: Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost always fatal. Due to its rarity, only few randomized controlled therapeutic trials are available. Recently, rituximab has been approved as first-line treatment for moderate and severe pemphigus vulgaris in Europe and the USA.Objectives: The Autoimmune blistering diseases Task Force of the European Academy of Dermatology and Venereology (EADV) has initiated a throughout update of the guideline for the management of patients with pemphigus. Results: The guidelines for the management of pemphigus were updated and the degree of consent among all task force members was included. The final version of the guideline was consented by the European Dermatology Forum (EDF) and several patient organisations.",

author = "Pascal Joly and Horwath, {Barbara Horwath} and Katerina Patsatsi and Soner Uzun and Rikke Bech and Stefan Beissert and Reuven Bergman and Philippe Bernard and Luca Borradori and Marzia Caproni and Fr{\'e}d{\'e}ric Caux and Giuseppe Cianchini and Maryam Daneshpazhooh and De Dipankar and Marian Dmochowski and Kossara Drenovska and Jan Ehrchen and Claudio Feliciani and Matthias Goebeler and Richard Groves and Claudia Guenther and Silke Hofmann and Dimitrios Ioannides and Cezary Kowalewski and Ralf Ludwig and Lim, {Yen Loo} and Branka Marinovic and Marzano, {Angelo Valerio} and Mascar{\'o}, {Jos{\'e} M.} and Daniel Mimouni and Murrel, {Dedee F} and Carlo Pincelli and Squarcioni, {Catherine Prost} and Mikl{\'o}s S{\'a}rdy and Jane Setterfield and Eli Sprecher and Snejina Vassileva and Katarzyna Wozniak and Savas Yayli and Giovanna Zambruno and Detlef Zillikens and Michael Hertl and Enno Schmid",

year = "2020",

month = aug,

day = "24",

doi = "10.1111/jdv.16752",

language = "English",

journal = "Journal of the European Academy of Dermatology and Venereology : JEADV",

issn = "1468-3083",

publisher = "Wiley",

}

Joly, P, Horwath, BH, Patsatsi , K, Uzun, S, Bech, R, Beissert, S, Bergman, R, Bernard, P, Borradori, L, Caproni , M, Caux, F, Cianchini, G, Daneshpazhooh, M, Dipankar, D, Dmochowski, M, Drenovska, K, Ehrchen, J, Feliciani, C, Goebeler, M, Groves, R, Guenther, C, Hofmann, S, Ioannides, D, Kowalewski, C, Ludwig, R, Lim, YL, Marinovic, B, Marzano, AV, Mascaró, JM, Mimouni, D, Murrel, DF, Pincelli, C, Squarcioni , CP, Sárdy, M, Setterfield, J, Sprecher, E, Vassileva, S, Wozniak, K, Yayli , S, Zambruno, G, Zillikens , D, Hertl , M & Schmid, E 2020, 'UPDATED S2K GUIDELINES ON THE MANAGEMENT OF PEMPHIGUS VULGARIS AND FOLIACEUS INITIATED BY THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV)', Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.16752

UPDATED S2K GUIDELINES ON THE MANAGEMENT OF PEMPHIGUS VULGARIS AND FOLIACEUS INITIATED BY THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV). / Joly, Pascal ; Horwath, Barbara Horwath; Patsatsi , Katerina et al.
In: Journal of the European Academy of Dermatology and Venereology : JEADV, 24.08.2020.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - UPDATED S2K GUIDELINES ON THE MANAGEMENT OF PEMPHIGUS VULGARIS AND FOLIACEUS INITIATED BY THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV)

AU - Joly, Pascal

AU - Horwath, Barbara Horwath

AU - Patsatsi , Katerina

AU - Uzun, Soner

AU - Bech, Rikke

AU - Beissert, Stefan

AU - Bergman, Reuven

AU - Bernard, Philippe

AU - Borradori, Luca

AU - Caproni , Marzia

AU - Caux, Frédéric

AU - Cianchini, Giuseppe

AU - Daneshpazhooh, Maryam

AU - Dipankar, De

AU - Dmochowski, Marian

AU - Drenovska, Kossara

AU - Ehrchen, Jan

AU - Feliciani, Claudio

AU - Goebeler, Matthias

AU - Groves, Richard

AU - Guenther, Claudia

AU - Hofmann, Silke

AU - Ioannides, Dimitrios

AU - Kowalewski, Cezary

AU - Ludwig, Ralf

AU - Lim, Yen Loo

AU - Marinovic, Branka

AU - Marzano, Angelo Valerio

AU - Mascaró, José M.

AU - Mimouni, Daniel

AU - Murrel, Dedee F

AU - Pincelli, Carlo

AU - Squarcioni , Catherine Prost

AU - Sárdy, Miklós

AU - Setterfield, Jane

AU - Sprecher, Eli

AU - Vassileva, Snejina

AU - Wozniak, Katarzyna

AU - Yayli , Savas

AU - Zambruno, Giovanna

AU - Zillikens , Detlef

AU - Hertl , Michael

AU - Schmid, Enno

PY - 2020/8/24

Y1 - 2020/8/24

N2 - Abstract:Background: Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost always fatal. Due to its rarity, only few randomized controlled therapeutic trials are available. Recently, rituximab has been approved as first-line treatment for moderate and severe pemphigus vulgaris in Europe and the USA.Objectives: The Autoimmune blistering diseases Task Force of the European Academy of Dermatology and Venereology (EADV) has initiated a throughout update of the guideline for the management of patients with pemphigus. Results: The guidelines for the management of pemphigus were updated and the degree of consent among all task force members was included. The final version of the guideline was consented by the European Dermatology Forum (EDF) and several patient organisations.

AB - Abstract:Background: Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost always fatal. Due to its rarity, only few randomized controlled therapeutic trials are available. Recently, rituximab has been approved as first-line treatment for moderate and severe pemphigus vulgaris in Europe and the USA.Objectives: The Autoimmune blistering diseases Task Force of the European Academy of Dermatology and Venereology (EADV) has initiated a throughout update of the guideline for the management of patients with pemphigus. Results: The guidelines for the management of pemphigus were updated and the degree of consent among all task force members was included. The final version of the guideline was consented by the European Dermatology Forum (EDF) and several patient organisations.

U2 - 10.1111/jdv.16752

DO - 10.1111/jdv.16752

M3 - Article

SN - 1468-3083

JO - Journal of the European Academy of Dermatology and Venereology : JEADV

JF - Journal of the European Academy of Dermatology and Venereology : JEADV

ER -

UPDATED S2K GUIDELINES ON THE MANAGEMENT OF PEMPHIGUS VULGARIS AND FOLIACEUS INITIATED BY THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV)

Abstract

Access to Document

Fingerprint

Cite this